Verastem Oncology
VSTM
#7322
Rank
NZ$0.73 B
Marketcap
NZ$9.72
Share price
-1.98%
Change (1 day)
-22.68%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: NZ$0.73 Billion

As of March 2026 Verastem Oncology has a market cap of NZ$0.73 Billion. This makes Verastem Oncology the world's 7322th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.73 B-30.17%
2025NZ$1.04 B258.02%
2024NZ$0.29 B-9.98%
2023NZ$0.32 B144.2%
2022NZ$0.13 B-75.64%
2021NZ$0.54 B9.1%
2020NZ$0.50 B214.4%
2019NZ$0.15 B-56.88%
2018NZ$0.36 B69.23%
2017NZ$0.21 B265.24%
2016NZ$59.81 M-40.42%
2015NZ$0.10 B-68.43%
2014NZ$0.31 B-9.5%
2013NZ$0.35 B61.48%
2012NZ$0.21 B

End of Day market cap according to different sources

On Mar 16th, 2026 the market cap of Verastem Oncology was reported to be:

NZ$0.87 Billion
by Nasdaq info icon info icon
NZ$0.74 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$262.72 B 35,791.60%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$38.11 B 5,106.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$183.58 B 24,980.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
NZ$20.62 M-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA